Association between rates of HIV testing and elimination of written consents in San Francisco [8]

JAMA

Volumn 297, Issue 10, 2007, Pages 1061-1062

  Zetola, Nicola M ^a   Klausner, Jeffrey D ^b   Haller, Barbara ^a   Nassos, Patricia ^a   Katz, Mitchell H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

CLINICAL PRACTICE; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH STATUS; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFORMED CONSENT; LABORATORY TEST; LETTER; LONG TERM CARE; MEDICAL CARE; MEDICAL ERROR; MEDICAL RECORD; MEDICAL STAFF; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

EID: 33947202616     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.10.1061     Document Type: Letter

References (3)

1. Glynn MK, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003 [abstract T1-B1101]. Presented at: The 2005 National HIV Prevention Conference, Atlanta, Ga; June 14, 2005.
2. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17.
3. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299-309.